Abstract Ubiquitination and subsequent degradation of pathway proteins is an important way of terminating an effector cell response. Three classes of enzymes: E1 ubiquitin activating enzymes, E2 ubiquitin conjugating enzymes, and E3 ubiquitin ligases, work sequentially to ubiquitinate selected substrates. Ndfip1 (Nedd4-family interacting protein 1) is a protein that activates the catalytic function of several related E3 ubiquitin ligases. Previous work from our lab showed that mice lacking Ndfip1 have increased numbers of TH17 cells and that Ndfip1 is expressed in T cells. Thus, we hypothesized that Ndfip1 has a T cell-intrinsic role in limiting TH17 cell differentiation. Using a mixed chimera model, we show that T cells that lack Ndfip1 are much more likely to produce IL-17A and GM-CSF, two proinflammatory cytokines produced by TH17 cells. Additionally, Ndfip1-deficient T cells produce more IL-17A and GM-CSF when cultured under TH17 polarizing conditions. These data may help to explain why mice that lack Ndfip1 are more susceptible to IL-17-mediated pathology in a DSS colitis model, compared to their Ndfip1-sufficient counterparts. This work reveals a biologically relevant role for Ndfip1 in limiting TH17 differentiation and GM-CSF production, as well as associated inflammatory pathology. We are now working to identify components of Ndfip1-mediated ubiquitin complexes and determine the underlying mechanism by which Ndfip1 limits proinflammatory cytokine production by TH17 cells.